Skip to content

Sophysa

Active in EUDAMED

Francefrom SRN EUDAMED FDA SRN FR-MF-000002870 FEI 3001587388

Sophysa is a medical device manufacturer based in France, with 151 devices listed in EUDAMED, FDA GUDID and FDA 510(k) (EU Class III, I and IIa; FDA Class II) and 2 FDA recalls as of 12 Nov 2026.

Devices
151
Registrations
EUDAMEDFDA
FDA recalls
22 ongoing

Registry facts

Counted by deviCERTS from registry records, 12 Nov 2026

Registries
  • EUDAMED 148
  • FDA GUDID 66
  • FDA 510(k) 3

A device listed in two registries counts in both.

Device classes
  • EU Class III 77
  • EU Class I 62
  • EU Class IIa 8
  • FDA Class II 3
  • EU Class IIb 1
Identifiers
  • EUDAMED SRN FR-MF-000002870
  • FDA FEI 3001587388
  • DUNS 262951353

At a glance

Counted by deviCERTS from registry records

EU certificates

2 of 2 in force.

See certificates

Market reach

European Union
EUDAMED actor, 2 certificates
United States
FDA establishment, FDA recalls

What Sophysa makes

Sophysa manufactures general-purpose pneumatic suction systems, adjustable valves for cerebrospinal fluid management, and burr hole reservoirs. Their product portfolio also includes catheter passers, locating instruments, and various patient monitor cables for blood pressure and temperature measurement.

The company is based in France, and its devices are categorized under Class I, Class II, Class III, Class IIa, and Class IIb. These products are listed in the EUDAMED database and have received FDA 510(k) clearance.

AI-generated from registry data, 4 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue151

Newest first, rows 1-50 of 151

Search and filter all 151 devices
Skip device list

Rows 1-50 of 151

Showing 1-50 of 151

Company details

EUDAMED record synced 7 Nov 2026

EUDAMED SRN
FR-MF-000002870
SRN (system / procedure pack)
FR-PR-000038440
FDA FEI number
3001587388
DUNS number
262951353
EU VAT number
FR06306979584
EUDAMED status
Active
EUDAMED registered name
SOPHYSA
Registered address
5, GUY MOQUET, 91400, ORSAY, France
Phone
+33169351055
PRRC contact
JULIE LOPEZ(public in EUDAMED)

EUDAMED certificates2

2 certificates2 valid, 0 expiredMDR 2next expiry 5 Mar 2030

EUDAMED certificates (2)

GMED SAS 0459 2 certificates

  • 40615 Active

    Quality management system EU MDR

    Issued
    28 Aug 2026
    Expires
    27 Aug 2031
  • 40171 Active Supplemented

    Quality management system EU MDR

    Issued
    3 Aug 2026
    Expires
    5 Mar 2030
    Reason
    Add device or group

FDA recalls2

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 0
  • 2023 0
  • 2024 2
  • 2025 0
  • 2026 0
  • 2024

    • 9 Apr 2024 Z-1825-2024 Class II Ongoing An increase in claims related to leakage of cerebrospinal fluid (CSF) from the proximal end of the catheter. In the event of a leak going undetected during implantation, it could pose an infectious risk to the patient. The cause of the leaks is indicated to be manufacturing error involving perforation of the inner channel of the catheter during stylet insertion. Distribution: Worldwide - US Nationwide distribution in the states of AZ, NY, TX and the countries of ARGENTINA, CHINA, CZECH…
      Full distribution text Worldwide - US Nationwide distribution in the states of AZ, NY, TX and the countries of ARGENTINA, CHINA, CZECH REPUBLIC, FRANCE, GREECE, HUNGARY, JAPAN, PAKISTAN, Portugal, ROMANIA, SOUTH AFRICA, SWEDEN, VIETNAM.
      Submission numbers: K162108, K062584
    • 9 Apr 2024 Z-1826-2024 Class II Ongoing An increase in claims related to leakage of cerebrospinal fluid (CSF) from the proximal end of the catheter. In the event of a leak going undetected during implantation, it could pose an infectious risk to the patient. The cause of the leaks is indicated to be manufacturing error involving perforation of the inner channel of the catheter during stylet insertion. Distribution: Worldwide - US Nationwide distribution in the states of AZ, NY, TX and the countries of ARGENTINA, CHINA, CZECH…
      Full distribution text Worldwide - US Nationwide distribution in the states of AZ, NY, TX and the countries of ARGENTINA, CHINA, CZECH REPUBLIC, FRANCE, GREECE, HUNGARY, JAPAN, PAKISTAN, Portugal, ROMANIA, SOUTH AFRICA, SWEDEN, VIETNAM.
      Submission numbers: K162108, K062584

FDA establishments1

Registered with the FDA under this company group, matched by name.

  • Sophysa SA US

Frequently asked questions

How many devices does SOPHYSA have in the registry?

The registry currently lists 151 devices for SOPHYSA. Devices recorded under merged duplicate company entries are counted once.

Which registries list SOPHYSA's devices?

Among its 50 most recently registered devices, SOPHYSA has devices listed in EUDAMED (50 devices).

What risk classes do SOPHYSA's devices fall under?

Among its 50 most recently registered devices, the classes recorded for SOPHYSA's devices are Class I, Class IIa and Class III. Each device page shows its own class and authorisation.

Are there FDA recall records for SOPHYSA?

FDA recall records list 2 recalls initiated by SOPHYSA, the most recent initiated on 9 Apr 2024. 2 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What EUDAMED certificates are recorded for SOPHYSA?

EUDAMED lists 2 certificates for SOPHYSA (quality management system) under MDR. 1 is recorded with the status issued. The most recent was issued on 28 Aug 2026.

What are the newest devices from SOPHYSA in the registry?

The most recently registered devices listed for SOPHYSA include PRESSIO® 3 - PRODLUŽOVACÍ KABEL K MONITORU PACIENTA - 3 PARAMETRY (ICP, ICT, MAP), VALVE AJUSTABLE SOPHY® MINI/ 8 PRESS. 80-400, PRESSIO® 3 - EXTENSION DE CÂBLE MONITEUR DE PATIENT - 3 PARAMÈTRES (PIC, TIC, PAM) and SOPHY® SM1-L VALVE / BURR HOLE RESERVOIR.

Generated automatically from registry data and not verified by a human reviewer.